What schedule is demerol classified under in the context of controlled substances?

Demerol, which is the brand name for meperidine, is classified as a Schedule II controlled substance. This classification is due to its high potential for abuse and dependence, which is characteristic of narcotic medications used for pain relief. Schedule II substances are recognized as having accepted medical uses, but they also carry strict regulations regarding their prescribing, dispensing, and storage due to the risks associated with misuse.

The scheduling of controlled substances takes into account their medical utility as well as the potential for abuse. In this case, being in Schedule II signifies that while demerol can effectively treat moderate to severe pain, there are serious risks of addiction and abuse, necessitating close oversight from healthcare providers and regulatory bodies.